NCT06126380Phase 2Enrolling by invitation

Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

Study sponsor: Eledon Pharmaceuticals

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-12Estimated
Enrollment · participants132Estimated
Source updated2025-12-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.